Treatments | Number of revertants (M±SD)/ plate and MI | ||||||||
---|---|---|---|---|---|---|---|---|---|
μg/plate | TA 98 | TA 100 | TA 102 | TA 97a | |||||
- S9 | + S9 | - S9 | + S9 | - S9 | + S9 | - S9 | + S9 | ||
HK | 0.0 a | 22 ± 2 | 32 ± 1 | 132 ± 6 | 123 ± 1 | 243 ± 4 | 391 ± 8 | 164 ± 4 | 163 ± 2 |
9.7 | 18 ± 4 (0.8) | 32 ± 1 (1.0) | 134 ± 4 (1.0) | 130 ± 6 (1.1) | 238 ± 8 (1.0) | 376 ± 7 (1.0) | 165 ± 5 (1.0) | 172 ± 10 (1.0) | |
19.5 | 23 ± 3 (1.0) | 34 ± 3 (1.1) | 129 ± 6 (1.0) | 128 ± 6 (1.0) | 231 ± 8 (0.9) | 363 ± 3 (0.9) | 165 ± 9 (0.9) | 187 ± 3 (1.1) | |
39.0 | 25 ± 3 (1.1) | 33 ± 4 (1.0) | 134 ± 5 (1.0) | 115 ± 8 (0.9) | 213 ± 4 (0.9) | 354 ± 4 (0.9) | 146 ± 5 (0.9) | 166 ± 5 (1.0) | |
58.5 | 25 ± 2 (1.1) | 28 ± 1 (0.8) | 112 ± 3 (0.8) | 134 ± 2 (1.1) | 201 ± 6 (0.8) | 398 ± 9 (1.0) | 175 ± 4 (1.1) | 172 ± 2 (1.0) | |
78.0 | 24 ± 5 (1.1) | 31 ± 2 (1.0) | 140 ± 9 (1.1) | 120 ± 8 (1.0) | 186 ± 2 (0.8) | 402 ± 3 (1.0) | 163 ± 8 (1.0) | 146 ± 4 (0.9) | |
Ctrol + | 1347 ± 88b | 1567 ± 115e | 1582 ± 98c | 1456 ± 78e | 1656 ± 60d | 1932 ± 97f | 1766 ± 49b | 1789 ± 89e |